Abstract

Particulates in Parenterals

Author(s): Allen Loyd V Jr

Issue: Jan/Feb 2000 - Compounding for Pain Management

Page(s): 43

Download in electronic PDF format for $75

Abstract

Particulates can be entrapped in the lungs, liver and spleen, and particles greater than 7 microns in diameter are threatening. In this brief discussion, the author covers sources of particulates and their detection. He ends by cautioning that pharmacists who do not have the necessary training, facilities and equipment should not be involved in sterile-products compounding; and that they should be familiar with the United States Pharmacopeia/National Formulary guidelines on the preparation of sterile products, in addition to other organizations’ guidelines.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jan/Feb 2000 Pg. 43	Particulates in Parenterals Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 219-228	Sterile Basics of Compounding: Particulates in Parenteral Preparations: Sources, Minimization, and Detection Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 395-404	Basics of Sterile Compounding: Particulate Matter Author(s): Akers Michael J
Sep/Oct 2021 Pg. 403-408	Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 11: Particulate Issues --- Silicone Oil in Vials, Cartridges, and Syringes Author(s): Allen Loyd V Jr
Mar/Apr 2003 Pg. 114-116	Autoclaves for the Sterilization of Compounded Parenteral Products Author(s): Rahe Hank
May/Jun 2018 Pg. 257-263	Trace Level Analysis of Airborne Hormone Particulates Author(s): Trimble John O, Hampton Shanna
Sep/Oct 2018 Pg. 369-384	Certification of Powder-containment Hoods for Nonsterile Compounding Author(s): Mulder Kyle, Dozzi Raphael
May/Jun 2020 Pg. 215-220	Sterile Basics: Intravenous Admixture Preparation Considerations, Part 4: Particulates Author(s): Allen Loyd V Jr
Jan/Feb 1998 Pg. 78	Standard Operating Procedure for Particulate Testing for Sterile Products Author(s): Allen Loyd V Jr
Sep/Oct 2018 Pg. 387-398	Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations Author(s): Ashe Krystina, Baskett Dustin
Jul/Aug 2019 Pg. 271-278	Contamination Control in Compounding Areas Author(s): Mulder Kyle, Gonzales Ben A
Sep/Oct 2015 Pg. 393-401	Sterile Filtration Author(s): Akers Michael J
Mar/Apr 2024 Pg. 120-127	Sterile Filtration Author(s): Akers Michael J
May/Jun 2006 Pg. 202-204	Quality-Control Analytical Methods: Particulate Matter in Injections: What is It and What are the Concerns? Author(s): Tran Tuan, Kupiec Thomas C, Trissel Lawrence A
May/Jun 2017 Pg. 193-203	Microbiologic Testing for 503A Sterile-Compounding Pharmacies Author(s): Mixon William, Roth Abby
Jul/Aug 2003 Pg. 281-285	Containment of Hazardous Particulates in the Compounding Pharmacy Author(s): Allen Loyd V Jr
May/Jun 2015 Pg. 232-238	Basics of Sterile Compounding: Contamination Control Author(s): Akers Michael J
Nov/Dec 2019 Pg. 511-518	Evaluation of Containment Ventilated Enclosure Performance in Absence of Negative Pressure Containment Secondary Engineering Control Author(s): Hutson Chad, Day A J
Jul/Aug 2013 Pg. 307-311	Quality Control Analytical Methods: End-preparation Assessments and Tests for Compounded Sterile Preparations Author(s): McElhiney Linda F
Mar/Apr 1997 Pg. 118-120 View Sample	Particle Size Distribution of Propofol Injection from Ampules and Vials: The Benefits of Filitration Author(s): Driscoll David F, Deaconess Beth Israel, Lawrence Kenneth R, Lewis Keith, Bistrian Bruce R